Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Critical Therapeutics to Present at the 2008 BIO CEO & Investor Conference on Tuesday, February 12.


LEXINGTON, Mass. -- Critical Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
, Inc. (Nasdaq: CRTX) announced today that it will present at the 2008 BIO bi·o  
n. pl. bi·os Informal
1. A biography.

2. A biographical sketch or outline.
 CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  & Investor Conference on Tuesday, February 12, 2008, at 3:30 p.m. (ET) at The Waldorf=Astoria in New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
.

Management will provide an update on the Company's operations, development pipeline and milestones. A live and archived webcast of this presentation will be available by logging on to the "Investors" section of the Company's website, www.crtx.com, and clicking the link labeled "Webcasts & Presentations."

About Critical Therapeutics

Critical Therapeutics, Inc. is developing and commercializing innovative products for respiratory, inflammatory and critical care diseases. The Company owns worldwide rights to two FDA-approved drugs for the prevention and chronic treatment of asthma in patients 12 years of age and older: twice-daily ZYFLO CR[TM] (zileuton zileuton /zi·leu·ton/ (zi-loo´ton) an inhibitor of leukotriene formation, used as an antiasthmatic.
Zileuton (Zyflo) 
) extended-release tablets and ZYFLO[R] (zileuton tablets). Critical Therapeutics is developing products for acute asthma attacks that lead patients to the emergency room and other urgent care settings. The Company also is developing therapies directed toward the body's inflammatory response. Critical Therapeutics is located in Lexington, Mass. For more information, please visit www.crtx.com.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Conference news
Date:Feb 7, 2008
Words:187
Previous Article:Cubist Pharmaceuticals Repurchases $50 Million of Its 2.25% Convertible Subordinated Notes Due June 15, 2013.
Next Article:WDF Services Corp. and Five Star Electric Corp. Merge to Form GreenStar Services, a Leading Mechanical, Electrical and Specialty Contractor.
Topics:



Related Articles
Gemin X Biotechnologies to Webcast Presentation at BIO CEO & Investor Conference.
Therapeutic Workshop Topics for BIO CEO & Investor Conference 2007 Now Available Online.
Media Registration for Tenth Annual BIO CEO & Investor Conference Now Available Online.
BIO CEO & Investor Conference Therapeutic Workshops Highlight Innovative Trends in Biotech Therapies.
OXiGENE to Present at BIO CEO and Investor Conference on February 12, 2008.
VIVUS to Present at the BIO CEO & Investor Conference 2008.
Introgen Therapeutics, Inc. to Present at BIO CEO & Investor Conference.
Tenth Annual BIO CEO & Investor Conference Brings Together Industry Leaders and Investors.
BIO Announces Initial Companies Selected to Present at the Seventh Annual Bio(R) Investor Forum.
Final Call to Register for BioPartnering Europe (BPE).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles